Concepedia

Peter Ruus

PR

Statistics

Publications

10

Citations

1.1K

H-Index

10

Active since

1994

Affiliations

Sanofi (Germany)(Current)

Leipzig University

Peter Ruus is an author at Sanofi (Germany) specializing in pharmacology, clinical pharmacology, and pharmacokinetics.

Publications per year

1994–2013

10

Publications

10

Oral administration of rac-α-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial

Simon N. Jacob, Peter Ruus, Róbert Hermann et al. · Free Radical Biology and Medicine · 1999 · 285 citations

, , +9

Pharmacodynamic characteristics of lixisenatide once daily versus liraglutide once daily in patients with type 2 diabetes insufficiently controlled on metformin

Christoph Kapitza, Thomas Först, Hans Veit Coester et al. · Diabetes Obesity and Metabolism · 2013 · 190 citations · Full text

, , +15

Effects of lixisenatide once daily on gastric emptying in type 2 diabetes — Relationship to postprandial glycemia

M. Lorenz, Claudia Pfeiffer, Axel Steinsträßer et al. · Regulatory Peptides · 2013 · 149 citations · Full text

, , +17

Plasma Kinetics, Metabolism, and Urinary Excretion of Alpha‐Lipoic Acid following Oral Administration in Healthy Volunteers

Jens Teichert, Róbert Hermann, Peter Ruus · The Journal of Clinical Pharmacology · 2003 · 146 citations

, , +14

Enantioselective pharmacokinetics and bioavailability of different racemic α-lipoic acid formulations in healthy volunteers

Róbert Hermann, G Niebch, Harald O. Borbe et al. · European Journal of Pharmaceutical Sciences · 1996 · 111 citations

, , +14

1–5 of 10